Glass-Coated Catheter Inserts Protect against Nosocomial Infection
By HospiMedica International staff writers Posted on 23 Oct 2019 |

Image: Aston researcher preparing a ZnO laced glass rod (Photo courtesy of Aston University).
A phosphate glass compound containing small amounts of zinc oxide (ZnO) can help eradicate the urinary tract infections (UTIs) that plague catheter patients, according to a new study.
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
To develop the new catheter coating, researchers at Aston University (Birmingham, United Kingdom) heated phosphate-based glass rods (P2O5)50(Na2O)20(CaO)30 in a furnace to over 1,000°C, before slowly cooling them down to room temperature. The rods were then separated into small discs and placed into contact with bacteria in petri dishes. The rods were laced with ZnO in various concentrations order to determine the antimicrobial effects of increasing ionic degradation. They found that while 1 and 3 mol% ZnO decreased glass degradation, a higher dissolution rate was observed for 5 and 10 mol%.
They found that the higher the ZnO concentration, the larger the effect against microorganisms known to cause hospital-acquired infections (HAIs). When in direct contact, the ZnO-doped glasses showed a complete kill within 24 hours against Escherichia coli, and a significant kill rate of methicillin-resistant Staphylococcus aureus (MRSA), with complete kill achieved after 48 hours. Cytotoxic studies showed no toxic effects on the viability of uroepithelial cells. The study was published in the October 2019 issue of Materials Science & Engineering C.
“Zinc oxide coated phosphate glass, inserted into catheters, has to potential to eradicate the most common bacteria in catheter-associated UTI, E.coli and Staphylococcus aureus,” said senior author Richard Martin, PhD, of the School of Engineering and Applied Science. “This is great news for patients requiring catheters, who would be at a much-reduced risk of contracting a potentially life-threatening UTI during a hospital stay. It is also good for healthcare systems, which could save millions in the costs associated with these infections.”
A UTI is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter inserted into the bladder through the urethra to drain urine, which are indicated in between 15-25% of hospitalized patients. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter.
Related Links:
Aston University
Latest Critical Care News
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
Channels
Surgical Techniques
view channel
Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
Aneurysms, especially when located in the brain, can be life-threatening if not treated effectively. Intracranial aneurysms, caused by the dilation of blood vessels due to weaknesses in the vessel wall,... Read more
New Surgical Technique Safely Removes Giant Nerve Tumors
Giant plexiform neurofibromas (PNF) are benign tumors commonly associated with neurofibromatosis Type 1 (NF1), a genetic disorder affecting approximately 1 in 3,000 live births. These tumors, which occur... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more